Propanc Biopharma, Inc.: Propanc Biopharma Establishes Joint Research Collaboration Agreement with the Universities of Jaén and Granada

Research Evaluates Effects of Against the Tumor Microenvironment Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel cancer treatments

Related Keywords

Granada ,Andalucísp ,Spain ,Spanish ,Kostenloser Wertpapierhandel ,Maria Angel Garcia ,James Nathanielsz ,Toledo Cutillas Msc ,Julian Kenyon ,Exchange Commission ,Research Collaboration Agreement ,University Of Ja ,Propanc Biopharma Inc ,University Of Granada ,Centre For Biomedical Research ,Company Mechanism Of Action ,Research Evaluates Effects ,Joint Research Collaboration Agreement ,Toledo Cutillas ,Professor Macarena Per ,Biomedical Research ,Professor Juan Marchal ,Professor Per ,Professor Marchal ,Chief Scientific Officer ,Chief Executive ,Propanc Biopharma ,Propanc ,Iopharma ,Stablishes ,Joint ,Research ,Collaboration ,Agreement ,Universities ,A 233 N ,